MedTrace Logo

Study to Evaluate the Efficacy and Safety of CKD-352

NCT04548427 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 283

Last updated 2021-06-01

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of CKD-352 in patients with dry eye disease

Conditions

Interventions

DRUG

CKD-352

Eye Drop

DRUG

Diquafosol Sodium 3%

Eye Drop

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Jong Su Lee, M.D, Ph.D · Pusan National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2021-05-07
Completion
2021-05-07

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04548427 on ClinicalTrials.gov